SILK — Silk Road Medical Balance Sheet
0.000.00%
- $1.12bn
- $1.02bn
- $177.13m
- 57
- 17
- 93
- 56
Annual balance sheet for Silk Road Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 90.7 | 147 | 110 | 214 | 181 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8.6 | 9.07 | 11.8 | 18 | 23.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 112 | 173 | 143 | 255 | 241 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6.13 | 5.64 | 12.9 | 14.5 | 14.6 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 137 | 179 | 157 | 270 | 265 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 16.9 | 19.6 | 26.1 | 24.5 | 30.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 65.5 | 71.8 | 77.4 | 106 | 114 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 71.9 | 108 | 79.2 | 164 | 151 |
Total Liabilities & Shareholders' Equity | 137 | 179 | 157 | 270 | 265 |
Total Common Shares Outstanding |